Exploring how epigenetic changes affect skin cancer development
Harnessing epigenetic therapy for cutaneous squamous cell carcinoma by targeting histone H3K9 methylation
This study is looking at how a specific gene might affect the development of skin cancer, especially in military personnel who are often exposed to the sun, with the hope of finding new ways to treat this common condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Minneapolis VA Medical Center NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10927704 on NIH RePORTER |
What this research studies
This research focuses on cutaneous squamous cell carcinoma (SCC), a common skin cancer that particularly affects military personnel due to high UV exposure. The study aims to understand the role of the hairless gene in regulating epigenetic changes that may contribute to SCC development. By investigating how this gene influences histone methylation, the research seeks to uncover new mechanisms behind SCC growth and potentially identify novel therapeutic targets. Patients may benefit from insights that could lead to improved treatment options for SCC.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a history of cutaneous squamous cell carcinoma, particularly those with significant UV exposure.
Not a fit: Patients with other types of skin cancer or those without a history of UV exposure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that more effectively target cutaneous squamous cell carcinoma.
How similar studies have performed: Previous research has shown promise in understanding epigenetic mechanisms in cancer, suggesting that this approach could yield valuable insights.
Where this research is happening
Minneapolis, United States
- Minneapolis VA Medical Center — Minneapolis, United States (Active)
Researchers
- Principal investigator: Goldfarb, Noah I — Minneapolis VA Medical Center
- Study coordinator: Goldfarb, Noah I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.